| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.28 | 0.02 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |